BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28528155)

  • 1. Serial OCT Imaging in Vascular Healing After Everolimus-Eluting Stent Implantation.
    Yano H; Horinaka S; Ishimitsu T
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):147-148. PubMed ID: 28528155
    [No Abstract]   [Full Text] [Related]  

  • 2. Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.
    de la Torre Hernández JM; Tejedor P; Camarero TG; Duran JM; Lee DH; Monedero J; Laso FS; Calderón MA; Veiga G; Zueco J
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):E67-73. PubMed ID: 26526783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study.
    Otsuki S; Brugaletta S; Sabaté M; Shiratori Y; Gomez-Monterrosas O; Scalone G; Romero-Villafañe S; Hernández-Enríquez M; Freixa X; Martín-Yuste V; Masotti M
    Cardiovasc Revasc Med; 2016 Jun; 17(4):241-7. PubMed ID: 27158001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
    Vesga B; Hernandez H; Moncada M; Gasior P; Higuera S; Dager A; Arana C; Delgado JA; Généreux P; Maehara A; Granada JF
    Coron Artery Dis; 2017 Mar; 28(2):126-134. PubMed ID: 27879518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
    Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study.
    Ishida K; Otsuki S; Giacchi G; Ortega-Paz L; Shiratori Y; Freixa X; Martín-Yuste V; Masotti M; Sabaté M; Brugaletta S
    Cardiovasc Revasc Med; 2017; 18(1):47-52. PubMed ID: 27634493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.
    Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):515-522. PubMed ID: 29159531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.
    Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serial optical coherence tomography imaging following aggressive stent expansion technique: insight from the MECHANISM study.
    Sasaki W; Ishida M; Itoh T; Uchimura Y; Oda H; Taguchi Y; Kaneko K; Sakamoto T; Goto I; Sakuma M; Terashita D; Otake H; Shinke T; Morino Y
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):419-428. PubMed ID: 33034867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of long-term in-stent vascular response between abluminal groove-filled biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent: 3-year OCT follow-up from the TARGET I trial.
    Xu B; Zhang YJ; Sun ZW; Qiao SB; Chen SL; Zhang RY; Pan DR; Pang S; Zhang Q; Xu L; Yang YJ; Leon MB; Gao RL
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1489-96. PubMed ID: 26208685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study.
    Shiratori Y; Brugaletta S; Alvarez-Contreras L; Azpeitia Y; Ospino N; Gaido S; Delahanty A; Santos A; Martin-Yuste V; Masotti M; Serruys PW; Windecker S; Sabaté M
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E428-36. PubMed ID: 23441068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.
    Jaguszewski M; Aloysius R; Wang W; Bezerra HG; Hill J; De Winter RJ; Karjalainen PP; Verheye S; Wijns W; Lüscher TF; Joner M; Costa M; Landmesser U
    JACC Cardiovasc Interv; 2017 Mar; 10(5):489-499. PubMed ID: 28279316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
    Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic stent recoil in severely calcified coronary artery lesions. A serial optical coherence tomography study.
    Amemiya K; Maehara A; Yamamoto MH; Oyama Y; Igawa W; Ono M; Kido T; Ebara S; Okabe T; Yamashita K; Isomura N; Mintz GS; Ochiai M
    Int J Cardiovasc Imaging; 2020 Sep; 36(9):1617-1626. PubMed ID: 32462449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study.
    Kim SJ; Lee H; Cho JM; Park CB; Kim W; Kato K; Yonetsu T; Kim CJ; Jang IK
    Coron Artery Dis; 2013 Aug; 24(5):431-9. PubMed ID: 23722649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.
    Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very late-phase vascular response after everolimus-eluting stent implantation assessed by optical coherence tomography.
    Khalifa AKM; Ino Y; Kubo T; Tanimoto T; Shimamura K; Shiono Y; Takahata M; Terada K; Higashioka D; Wada T; Taruya A; Emori H; Katayama Y; Kashiwagi M; Kuroi A; Matsuo Y; Fujita S; Tanaka A; Hozumi T; Akasaka T
    Int J Cardiovasc Imaging; 2020 Sep; 36(9):1627-1635. PubMed ID: 32385540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neointimal response to everolimus-eluting bioresorbable scaffolds implanted at bifurcating coronary segments: insights from optical coherence tomography.
    Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):169-175. PubMed ID: 27757563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomography visualization of stent deformation with subsequent thrombus adhesion at very early phase after everolimus-eluting stent implantation: a case report.
    Yamamura S; Fujisue K; Tsujita K; Sakamoto K; Miyazaki Y; Kaikita K; Hokimoto S; Ogawa H
    BMC Cardiovasc Disord; 2016 May; 16():116. PubMed ID: 27245071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restenosis After Drug-Eluting Stent Implantation in a Patient With Polycythemia Vera: Optical Coherence Tomography and Pathological Findings.
    Fujino A; Hao H; Kajimoto N; Kawakami R; Imanaka T; Fujii K; Abe T; Ishihara M; Hirota S
    JACC Cardiovasc Interv; 2015 Jun; 8(7):e111-2. PubMed ID: 26003023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.